{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:40:44Z","timestamp":1791276044032,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1093\/toxsci\/kfn157","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T23:08:38Z","timestamp":1217372918000},"page":"153-161","source":"Crossref","is-referenced-by-count":188,"title":["Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells"],"prefix":"10.1093","volume":"106","author":[{"given":"Yvonne","family":"Will","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Dykens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashi","family":"Nadanaciva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Marroquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shem","family":"Patyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart A.","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,29]]},"reference":[{"key":"key\n\t\t\t\t20170315204436_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/exnr.2000.7438","article-title":"Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: Evidence for reduced sensitivity of brain mitochondria","volume":"164","year":"2000","journal-title":"Exp. Neurol."},{"key":"key\n\t\t\t\t20170315204436_bib2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170315204436_bib3","article-title":"ODAC briefing document, NDA 21-986 02-June-2006 Applicant","author":"Dasatinib (BMS-354825)","year":"2006"},{"key":"key\n\t\t\t\t20170315204436_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170315204436_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","year":"2007","journal-title":"Nat. Rev. Cancer."},{"key":"key\n\t\t\t\t20170315204436_bib6","year":"2006"},{"key":"key\n\t\t\t\t20170315204436_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/toxsci\/kfj208","article-title":"Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes","volume":"92","year":"2006","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170315204436_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","year":"2006","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170315204436_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170315204436_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/mgme.2001.3243","article-title":"Anthracycline-induced cardiac injury using a cardiac cell line: Potential for gene therapy studies","volume":"74","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170315204436_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: Replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","year":"2007","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170315204436_bib12","doi-asserted-by":"crossref","first-page":"C565","DOI":"10.1152\/ajpcell.00146.2003","article-title":"Pyruvate and citric acid cycle carbon requirements in isolated skeletal muscle mitochondria","volume":"286","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"key\n\t\t\t\t20170315204436_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tiv.2007.01.011","article-title":"Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays","volume":"21","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"key\n\t\t\t\t20170315204436_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170315204436_bib15","year":"2007"},{"key":"key\n\t\t\t\t20170315204436_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00280-003-0756-z","article-title":"Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules","volume":"53","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170315204436_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.snb.2007.09.004","article-title":"Data analysis algorithm for high throughput enzymatic oxygen consumption assays based on quenched-fluorescence detection","volume":"129","year":"2008","journal-title":"Sensors Actuators B"},{"key":"key\n\t\t\t\t20170315204436_bib18","article-title":"Morphological alterations induced by doxorubicin on H9c2 myoblasts: Nuclear, mitochondrial, and cytoskeletal targets","year":"2008","journal-title":"Cell Biol. Toxicol."},{"key":"key\n\t\t\t\t20170315204436_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0076-6879(67)10016-5","article-title":"Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small-scale","volume":"10","year":"1967","journal-title":"Methods Enzymol."},{"key":"key\n\t\t\t\t20170315204436_bib20","year":"2007"},{"key":"key\n\t\t\t\t20170315204436_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1634\/theoncologist.12-4-426","article-title":"Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: A review of four phase I trials in patients with advanced refractory solid tumors","volume":"12","year":"2007","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20170315204436_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12012-007-0008-2","article-title":"Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis","volume":"7","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"key\n\t\t\t\t20170315204436_bib23","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/nprot.2006.351","article-title":"Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes","volume":"1","year":"2006","journal-title":"Nat. Protoc."},{"key":"key\n\t\t\t\t20170315204436_bib24","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin","volume":"61","year":"2001","journal-title":"Cancer Res."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/106\/1\/153\/10999752\/kfn157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T21:20:49Z","timestamp":1557696049000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/1707905\/Effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,7,29]]},"published-print":{"date-parts":[[2008,11]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfn157","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,29]]}}}